Research classification: Animal behavioral and limited clinical literature
Compound overview
Selank is a synthetic heptapeptide related to the endogenous peptide tuftsin.
Published research
Researchers have examined Selank in animal behavioral paradigms and investigations of peptide signaling. A 2017 rat study evaluated responses under a chronic mild stress model; other studies investigated possible receptor and enzyme-related mechanisms.
Evidence limitations
Animal behavior tests and small or geographically limited clinical studies do not establish broad clinical efficacy, long-term safety, or regulatory approval in the United States.
Primary publications and technical references
- Selank rat stress-model study (2017) — view source
- Selank molecular research review (2018) — view source
Literature summaries are educational and refer only to the specific preparations and methods studied by the cited authors. These publications do not demonstrate that any APEP Biolabs material is suitable for human or veterinary use. Not medical advice. Laboratory research only. Do not administer or consume research materials.